UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008746
Receipt number R000010270
Scientific Title Analysis of C-C chemokine receptor type 5 antagonist, as an add-on treatment for HIV-1 patients with virological response but no immunological response: a pilot study
Date of disclosure of the study information 2012/08/21
Last modified on 2017/12/23 09:37:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of C-C chemokine receptor type 5 antagonist, as an add-on treatment for HIV-1 patients with virological response but no immunological response: a pilot study

Acronym

Analysis of C-C chemokine receptor type 5 antagonist, as an add-on treatment for HIV-1 patients with virological response but no immunological response

Scientific Title

Analysis of C-C chemokine receptor type 5 antagonist, as an add-on treatment for HIV-1 patients with virological response but no immunological response: a pilot study

Scientific Title:Acronym

Analysis of C-C chemokine receptor type 5 antagonist, as an add-on treatment for HIV-1 patients with virological response but no immunological response

Region

Japan


Condition

Condition

HIV-1 infection

Classification by specialty

Hematology and clinical oncology Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to determine the efficacy and the safety of maraviroc, a C-C chemokine receptor type 5 (CCR5) antagonist, as an add-on treatment to optimized background anti-retroviral therapy in treatment-experienced patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The changes of CD4+ T cell count from baseline to 24, 48 and 96 weeks.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Maraviroc (150-300mg twice daily), as an add-on treatment to optimized background anti-retroviral therapy in treatment-experienced patients.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with HIV-1 infection
2. Age > 20 years old
3. Patients who have received > 3 classes of anti-HIV drugs for more than 48 weeks
4. Patients who were not changed anti-retroviral therapy regimen for more than 24 weeks
5. Patients with a CD4+ T cell count < 350 cells/microL
6. Patients who were not experienced a CCR5 antagonist treatment
7. No pregnat and lactating woman
8. Completed the written informed consent

Key exclusion criteria

1. Patients who could be changed anti-retroviral therapy regimen during the research
2. Patients with hypersensivity to CCR5 antagonist
3. Patients with severe underlyng heart diseases
4. Patients with liver cirrhosis or liver dysfunction: AST or ALT > 3 upper limit of normality
5. Patients with renal dysfunction: eGFR<60mL/min/1.73m2
6. Patients with neutrophil< 1,000/microL, hemoglobin<10g/dL, or platelet< 100,000/microL
7. Patients with severe infectious diseases such as mycobacterium infection, deep fungal infection, cytomegalovirus infection

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Jun Hayashi

Organization

Kyushu-University Hospital

Division name

Department of General internal medicine

Zip code


Address

3-1-1, Maidashi, Higashi-ku, Fukuoka, Japan

TEL

092-642-5909

Email

hayashij@gim.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masayuki Murata

Organization

Kyushu-University Hospital

Division name

Department of General internal medicine

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-642-5909

Homepage URL


Email

mmurata@gim.med.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu-University Hospital

Institute

Department

Personal name



Funding Source

Organization

Kyushu-University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

九州大学病院(福岡県)


Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 10 Month 27 Day

Date of IRB


Anticipated trial start date

2011 Year 10 Month 27 Day

Last follow-up date

2015 Year 07 Month 31 Day

Date of closure to data entry

2016 Year 02 Month 29 Day

Date trial data considered complete

2016 Year 02 Month 29 Day

Date analysis concluded

2016 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 08 Month 21 Day

Last modified on

2017 Year 12 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010270


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name